Hematological Tumors
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors (NCT05489276) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-03-22 |
Track Hematological Tumors automatically
Every clearance here is in the API, with alerts when new ones post.